RSS feed

Publications by Skjalg Bruheim

16 publications found

Original articles

Wendel T, Zhen Y, Suo Z, Bruheim S, Wiedlocha A (2015)
The novel HSP90 inhibitor NVP-AUY922 shows synergistic anti-leukemic activity with cytarabine in vivo
Exp Cell Res, 340 (2), 220-6
DOI 10.1016/j.yexcr.2015.12.017, PubMed 26748184

Bruheim S, Sandvold ML, Mælandsmo GM, Fodstad O (2013)
Antitumor activity of elacytarabine combined with bevacizumab, cetuximab and trastuzumab in human NSCLC xenografts
Anticancer Res, 33 (9), 3615-21
PubMed 24023287

Bruheim S, Kristian A, Uenaka T, Suo Z, Tsuruoka A, Nesland JM, Fodstad Ø (2011)
Antitumour activity of oral E7080, a novel inhibitor of multiple tyrosine kinases, in human sarcoma xenografts
Int J Cancer, 129 (3), 742-50
DOI 10.1002/ijc.25922, PubMed 21225632

Wang B, Howel P, Bruheim S, Ju J, Owen LB, Fodstad O, Xi Y (2011)
Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array
PLoS One, 6 (2), e17167
DOI 10.1371/journal.pone.0017167, PubMed 21347261

Olberg DE, Cuthbertson A, Solbakken M, Arukwe JM, Qu H, Kristian A, Bruheim S, Hjelstuen OK (2010)
Radiosynthesis and biodistribution of a prosthetic group (¹⁸F-FENMA) conjugated to cyclic RGD peptides
Bioconjug Chem, 21 (12), 2297-304
DOI 10.1021/bc1003229, PubMed 21070000

Bergman AM, Adema AD, Balzarini J, Bruheim S, Fichtner I, Noordhuis P, Fodstad O, Myhren F, Sandvold ML, Hendriks HR, Peters GJ (2010)
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models
Invest New Drugs, 29 (3), 456-66
DOI 10.1007/s10637-009-9377-7, PubMed 20066470

Bruheim S, Xi Y, Ju J, Fodstad O (2009)
Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide
Clin Cancer Res, 15 (23), 7161-9
DOI 10.1158/1078-0432.CCR-08-2816, PubMed 19920113

Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, Fodstad O, Ju J (2009)
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
Oncogene, 28 (46), 4065-74
DOI 10.1038/onc.2009.274, PubMed 19734943

Høyem S, Bruheim S, Maelandsmo G, Olberg DE, Brudeli B, Asberg A, Klaveness J, Rongved P (2009)
Didanosine ester prodrugs: synthesis, albumin binding properties and pharmacokinetic studies in rats
Eur J Med Chem, 44 (10), 3874-9
DOI 10.1016/j.ejmech.2009.04.008, PubMed 19433342

Nakajima G, Patino-Garcia A, Bruheim S, Xi Y, San Julian M, Lecanda F, Sierrasesumaga L, Müller C, Fodstad O, Ju J (2008)
CDH11 expression is associated with survival in patients with osteosarcoma
Cancer Genomics Proteomics, 5 (1), 37-42
PubMed 18359978

Matsumoto T, Bohman S, Dixelius J, Berge T, Dimberg A, Magnusson P, Wang L, Wikner C, Qi JH, Wernstedt C, Wu J, Bruheim S, Mugishima H, Mukhopadhyay D, Spurkland A, Claesson-Welsh L (2005)
VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis
EMBO J, 24 (13), 2342-53
DOI 10.1038/sj.emboj.7600709, PubMed 15962004

Bruheim S, Bruland OS, Breistol K, Maelandsmo GM, Fodstad O (2004)
Human osteosarcoma xenografts and their sensitivity to chemotherapy
Pathol Oncol Res, 10 (3), 133-41
DOI 10.1007/BF03033741, PubMed 15448748

Bruheim S, Krobert KA, Andressen KW, Levy FO (2003)
Unaltered agonist potency upon inducible 5-HT7(a) but not 5-HT4(b) receptor expression indicates agonist-independent association of 5-HT7(a) receptor and Gs
Recept Channels, 9 (2), 107-16
DOI 10.1080/10606820308245, PubMed 12916471

Other articles

Hoyem S, Bruheim S, Maelandsmo G, Standal M, Olberg DE, Brudeli B, Asberg A, Klaveness J, Rongved P (2009)
Didanosine ester prodrugs: Synthesis, albumin binding properties and pharmacokinetic studies in rats (vol 44, pg 3874, 2009)
Eur. J. Med. Chem., 44 (11), 4786
DOI 10.1016/j.ejmech.2009.08.006

Theses

Bruheim S (2010)
Preclinical studies of human osteosarcoma: therapy response and search for biomakers
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 967, 1 b. (flere pag.)
BIBSYS 10127971x, ISBN 978-82-8072-606-3

Bruheim S (2001)
Comparison of adenylyl cyclase stimulation by the 5-HT₄(b) and 5-HT₇(a) receptors in an inducible expression system
S. Bruheim, Oslo, 77 s.
BIBSYS 011077298